Login
Navigate Fool.com
Will EXAS beat
the market?

EXACT Sciences Corp

NASDAQ: EXAS

Community Rating: 2 Stars: Unattractive

12.90 0.07 (0.55%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.87
Previous Close $12.83
Daily Range $12.60 - $13.16
52-Week Range $6.93 - $14.42
Market Cap $826.8M
P/E Ratio -14.92
Dividend (Yield) $0.00 (0.0%)
Volume 1,310,875
Average Daily Volume 1,123,182
Current FY EPS -$0.74

How do you think EXAS
will perform against the market?

Top EXAS Bull/Bear Pitches

 

NHWeston (9.85)
Submitted June 1, 2011

Exact Sciences stakes its future on a pioneering and extremely promising gambit - replacing the colonoscopy with a highly-reliable, completely non-invasive test for rectal and intestinal cancer. Its t … More

0 Replies Reply Report this Post
 

zzlangerhans (< 20)
Submitted October 24, 2011

Exact's share price seems to be getting ahead of itself yet again as the Cologuard trial enters the early stages of an enrollment process that will likely extend at least another 12 months. That means … More

0 Replies Reply Report this Post

News & Commentary Rss Feed

Here's What This Top-Earning Billionaire Has Been Buying

It can pay off to keep an eye on strong performers.

Exact Sciences Floats New Stock Issue

The company aims to raise nearly $64 million from the offering.

Healthcare Stocks Posting Moderate Gains; Exact Sciences Nets $64 Mln From Offering, Shares Rise 2%

Sector Update: Healthcare

Exact Sciences Prices Public Offering of Common Stock

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

Exact Sciences Announces Proposed Public Offering of Common Stock

Exact Sciences Submits Final Module and Completes Cologuard Premarket Approval Application to FDA, E

Exact Sciences to Participate in June Investor Conferences

Why Exact Sciences Is Poised to Underperform

Market-lagging returns could be written in this 2-Star.

See More EXAS News...

Sector

Healthcare

Industry

Drugs

EXACT Sciences Corp (EXAS) Description

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer. Website: http://www.exactsciences.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks